Romo1-induced ROS is reported to contribute cancer cell proliferation through extracellular signal-regulated kinases (ERK) activation and constitutive activation of nuclear factor kappa B (NF-kB)[9, 11]. This evidence concerns the gene NFKB1 and cancer.